Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FDG PET/MRI vs PET/CT in Pituitary Microadenoma
NCT03404414Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Feb 2013
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Peking Union Medical College Hospital. Primary endpoint: Standardized uptake value of 18F-FDG in pituitary adenoma at 5 years. Status: unknown.
Beyond the preview
Go deeper on NCT03404414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03404414.